EP3829502A1 - Vorrichtung und verfahren zur erzeugung einer aperturblende in einer intraokularlinse - Google Patents
Vorrichtung und verfahren zur erzeugung einer aperturblende in einer intraokularlinseInfo
- Publication number
- EP3829502A1 EP3829502A1 EP19749296.0A EP19749296A EP3829502A1 EP 3829502 A1 EP3829502 A1 EP 3829502A1 EP 19749296 A EP19749296 A EP 19749296A EP 3829502 A1 EP3829502 A1 EP 3829502A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- laser
- intraocular lens
- aperture
- eye
- unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 22
- 230000005540 biological transmission Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims description 32
- 230000008859 change Effects 0.000 claims description 17
- 230000000007 visual effect Effects 0.000 claims description 17
- 238000010521 absorption reaction Methods 0.000 claims description 14
- 210000001747 pupil Anatomy 0.000 claims description 13
- 238000002513 implantation Methods 0.000 claims description 9
- 238000004590 computer program Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000004478 pupil constriction Effects 0.000 claims description 5
- 230000000638 stimulation Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 17
- 208000014733 refractive error Diseases 0.000 abstract description 12
- 230000004438 eyesight Effects 0.000 abstract description 10
- 238000012937 correction Methods 0.000 abstract description 4
- 230000003902 lesion Effects 0.000 abstract description 4
- 230000006872 improvement Effects 0.000 abstract description 3
- 230000003203 everyday effect Effects 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 74
- 210000001525 retina Anatomy 0.000 description 20
- 210000004087 cornea Anatomy 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 12
- 238000003384 imaging method Methods 0.000 description 11
- 208000029091 Refraction disease Diseases 0.000 description 10
- 230000004430 ametropia Effects 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 239000007943 implant Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 8
- 208000006550 Mydriasis Diseases 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 208000002177 Cataract Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 230000004305 hyperopia Effects 0.000 description 5
- 208000001491 myopia Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 201000009310 astigmatism Diseases 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 230000004379 myopia Effects 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 206010027646 Miosis Diseases 0.000 description 3
- 230000004308 accommodation Effects 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 201000006318 hyperopia Diseases 0.000 description 3
- 230000003547 miosis Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010020675 Hypermetropia Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000003763 carbonization Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012014 optical coherence tomography Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 201000010041 presbyopia Diseases 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000036040 emmetropia Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/024—Methods of designing ophthalmic lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/06—Lenses; Lens systems ; Methods of designing lenses bifocal; multifocal ; progressive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/0087—Lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
- A61F2009/00895—Presbyopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
Definitions
- the present invention relates to the field of devices intended for correcting or reducing ametropia in the eye, and more particularly to a device for producing an aperture stop in an (implanted) intraocular lens (IOL) in an eye, with which the depth of field of the eye is increased , which is particularly useful for improving near vision of an eye implanted with a monofocal IOL.
- IOL intraocular lens
- Defective vision of the (natural) eye is generally remedied through glasses or contact lenses.
- ametropia an optically infinite object with relaxed ciliary muscle (remote accommodation) is not sharply imaged on the retina.
- myopia nearsightedness
- Glasses or contact lenses that act as diverging lenses can reduce the refractive power so that a sharp image is shown on the retina.
- hyperopia farsightedness
- the refractive power of the eye media is too low in relation to the length of the eyeball.
- a collective lens as glasses or contact lens can correct the ametropia. If the ametropia is only present on one level, one speaks of astigmatism (long-sightedness). Corresponding cylindrical lenses can also correct the ametropia here as glasses or contact lenses.
- implants can be inserted into the cornea, which should correct the ametropia by their optical refractive power or by their biomechanical effect (e.g. by changing the curvature of the cornea).
- Intraocular lenses can also be implanted in the eye to correct ametropia. These can act in addition to the natural eye lens or replace the natural eye lens.
- Cataract is an age-related eye disease in which the natural lens of the eye becomes cloudy and loses transparency. Such cloudy lenses are usually surgically removed from the eye and replaced with an artificial lens implant (intraocular lens (IOL)). Such operations are among the most frequently performed surgical procedures.
- IOL intraocular lens
- a clear, not cloudy lens can be replaced by an IOL.
- RLA refractive lens exchange
- the eye After removing the natural lens, the eye can no longer adjust (accommodate) to different viewing distances.
- the IOL is usually calculated in such a way that optimal vision is possible in the distance.
- Reading glasses are required for close-up viewing (such as reading).
- So-called accommodating intraocular lenses like the natural lens Current research is focusing on the retina at a desired distance. However, satisfactory results are not yet known.
- So-called multifocal intraocular lenses offer the possibility to largely do without glasses by creating two or more foci, so that objects from afar, from the intermediate area and up close are partially sharply depicted on the retina. The disadvantage of these lenses is that weak double images are generated and reduced contrast vision has to be accepted.
- LOLs with an extended depth of focus (EDOF) work in a similar way. Due to their external shape and thus refractive power, they create an elongated focal point in order to increase the depth of field.
- the implant solutions also include a group of implants that make the principle of the stenopean gap usable (pinhole effect).
- the pinhole reduces distracting edge rays and thereby reduces spherical aberration in imaging.
- the circles of confusion on the retina are reduced and thus the depth of field during imaging is increased.
- ametropic eyes gain greater visual acuity when looking through a pinhole.
- This approach can also be used to enable or improve reading ability after IOL implantation without having to wear glasses. If the depth of field is increased, you can also use a non-accommodating eye (such as a monofocal IOL) to see objects nearby and far away.
- an approximately 5 ⁇ m thick plastic disc with an open inner diameter of approximately 1.6 mm and an outer diameter of 3.8 mm is inserted centrally into the cornea of the eye. Surgically, this usually happens by using a laser to prepare a pocket in the cornea in which the implant is fixed.
- an artificial intraocular lens is implanted in the eye.
- the natural lens is removed.
- a pinhole with an approx. 1.36 mm free inside diameter and 3.23 mm outside diameter, as illustrated in FIGS. 2a and 2b, the reference symbol 2 the IOL and the reference symbol 6 the Pinhole or aperture called.
- the pinhole effect can also be used with the help of a contact lens.
- contact lenses can usually move easily on the cornea. The central opening is moved out of the visual axis so that optimal vision is impaired. Examples from the prior art relating to the utilization of the pinhole effect can be found, for example, in US 4,955,904, US 5,757,458, US 5,980,040, WO 2011/020078 A1 and US 2013/131795 A1.
- FIGS. 1a and 1b are intended to illustrate the effect of the increased depth of field by introducing a pinhole 6.
- the depth of field 7 for imaging increases with suitable dimensioning of the aperture 6 to such an extent that both for close objects 4 and for light incident from a distance 3 there is a sufficiently sharp image on the retina 9.
- Glasses can be damaged or lost in everyday life. Depending on the environment, they can become dirty or misty. Irregular ametropia, beyond myopia, hyperopia or astigmatism, can only be corrected inadequately or not at all, which also applies to contact lenses, which also require a certain skill when inserting and removing.
- IOLs are implanted in the remaining capsular bag of the natural lens. It can happen that the positioning of the IOL is not optimal. In addition, even if the IOL is well positioned in the postoperative course, the capsular bag and the zonular fibers holding it change their shape, thereby moving the IOL to a new position. The imaging elements of the eye (cornea, pupil, IOL, macula) are then no longer on one axis and the image quality is reduced accordingly.
- LAL light adjustable lenses
- ultra-short pulses can be used to cause (a) change (s) in the refractive index of the IOL material.
- concentric ring structures are produced which, according to the principle of diffractive optics or according to the principle of Fresnel zone plate, change the refractive power of the IOL partially or completely.
- the refractive index can be changed using ultrashort laser pulses, in some cases using conventional IOL materials. This is based on the nonlinear absorption (multiphoton absorption) of the laser pulses in the transparent IOL. As a result, free electrons are generated in the focus of the laser light, which in turn trigger local chemical reactions that directly or indirectly change the optical refractive index of the material. However, the material remains transparent overall and is not destroyed.
- the disadvantage of this method is that the positioning of the laser focus requires very high accuracy. In particular when generating diffractive structures within the IOL, positioning accuracies in the order of magnitude of the wavelength of the light are necessary. In an implanted lens in the patient's eye, this requirement represents a major technical challenge. More detailed descriptions of the embodiments of the utilization of the subsequent change in the refractive index of the implanted IOL can be found, for example, in US 6,905,641, US 2016/074967 A1, WO 2017/221068 A1 and US 2017/181 846 A1.
- One aim on which the present invention is based is in particular to make it possible to increase the depth of field of implanted IOLs and thus to restore or at least improve the reading ability of the eye.
- a device for producing an aperture diaphragm in an artificial intraocular lens implanted in an eye is provided with a control unit for a laser unit, the control unit being designed to control the laser unit for producing the aperture diaphragm in the intraocular lens, the Aperture diaphragm serves to enlarge the depth of field of the eye and is formed by laser-induced changes in the material of the intraocular lens, which reduce light transmission through an aperture area of the intraocular lens surrounding an aperture opening, the control unit being designed to control the laser unit in such a way that the generation the aperture stop starts from a predetermined germ zone in the intraocular lens.
- an intraocular lens for implantation in an eye with a predetermined germ zone in the intraocular lens, the germ zone being designed for linear absorption of energy supplied by laser
- a method for generating control commands for a laser unit for producing an aperture stop in an artificial intraocular lens implanted in an eye the control commands the Initiate the laser unit to generate the aperture diaphragm in the intraocular lens, the aperture diaphragm serving to enlarge the depth of field of the eye and being formed by laser-induced changes in the material of the intraocular lens which reduce light transmission through an aperture area of the intraocular lens surrounding an aperture opening
- the control commands cause the laser unit to produce the aperture diaphragm in such a way that the generation of the aperture diaphragm starts from a predetermined germ zone in the intraocular lens
- the invention provides for an aperture (pinhole) in an IOL already implanted in the eye.
- the aperture is created without surgically opening the eye.
- the IOL that has already been implanted can be made of any material that is currently implanted or previously implanted according to the prior art. Irrespective of this, the use of an IOL can also be provided, the material of which is particularly suitable for creating an aperture after the insertion of the IOL. Since the invention enables the aperture to be attached in a non-invasive form (in the sense that no further opening of the eye is provided after the insertion of the IOL), a sterile environment (operating room) is not required for the creation of the aperture.
- the aperture is preferably generated at a point in time at which the previously operated eye has (again) stabilized after the implantation of an IOL. It is particularly advantageous if the positioning of the IOL is stable, for example the capsular bag in which the IOL is located and the adjacent zonular fibers remain stable in shape and the positioning of the IOL does not change or changes only marginally. Typically, this is the case three months after implantation of the IOL.
- An aperture subsequently inserted into a stable eye and non-invasively also advantageously allows e.g. the size of the opening of the aperture (the central, translucent part of the mask) can be adapted to the visual requirements.
- the size of the opening enables an optimal ratio between the depth of field to be created for the eye and the amount of light that reaches the retina (brightness) to be calculated and implemented.
- the material of the IOL is changed in such a way that the area irradiated and influenced by the laser absorbs visible light or scatters it so strongly that hardly any light passes through this area to the retina arrives, preferably less than 20% of the incident light being transmitted and reaching the retina (9) of the eye
- the material can be converted from transparency to non-transparency by photochemical means or indirectly through thermal effects.
- the conversion process can also be photo-disruptive. This means that cracks or similar changes occur in the material due to the laser effect, which strongly scatter visible light.
- Ultra-short is the term used for pulses with a duration of less than one picosecond (10 12 s).
- Such disruption processes are known per se, for example, in connection with the eye, for example from applications such as refractive corneal surgery, in which the laser pulses make incisions in the cornea in order to produce tissue flaps or to remove tissue. It is also known that ultrashort laser pulses near or just below the disruption threshold influence natural tissue photochemically and in particular change the optical refractive index. Mechanisms of this type have also already been used to correct ametropia in the eye.
- the cornea of the eye should remain optically clear after the laser surgery.
- a scar can form in the cornea in the postoperative course, which leads to optical scattering phenomena.
- this is undesirable and attempts have traditionally been made to avoid such situations.
- ultrashort pulses for the treatment of presbyopia
- the ultrashort pulses cut the lens material that has hardened with age and thereby restore the flexibility and deformability of the eye lens in order to be able to deform the lens again during the accommodation process.
- the goal is to dose the laser pulses so that the lens remains optically clear after the laser intervention in order to avoid undesired glare effects.
- the laser parameters can be designed in such a way that light incident on the lesions generated by the laser pulses and remaining in the eye lens is diffracted or scattered. If a large number of such lesions are created, image-forming properties can be created within the eye lens according to the principle of diffractive optics. With the help of these image-forming properties, vision defects of the eye can be corrected.
- the area irradiated by the laser either remains clear and without an optical effect, or it contributes to the imaging by changing the refractive power (refractive) or scattering (diffractive).
- the lens components that are fragmented by the laser are surgically removed. It has been realized within the scope of the present invention that it is possible to continue the implanted intraocular lens, in particular even when it and the eye have stabilized again after the intervention, by laser exposure and with a view to the actual situation in the eye to adapt that a processed area becomes (sufficiently) opaque to be used as an aperture. With appropriate programming of the laser beam, pinholes can be created in the implanted intraocular lens, for example.
- This laser-generated aperture can be used to block the edge rays of the incident light according to the principle of the stenopean gap (pinhole effect).
- the marginal rays of an optical system are subject to larger imaging errors (aberrations). Hiding these marginal rays serves to improve the imaging quality of the eye and in particular to increase the depth of field of the eye. If the depth of field is increased, even with a non-accommodating (presbyopic) eye, you will be able to see objects nearby and far away.
- the device comprises an alignment unit for aligning and / or fixing the eye and a light stimulation unit for light stimulation of the eye in order to bring about pupil constriction, the control unit being designed to create the laser unit on the basis of the pupil constriction to control markings that define the aperture opening in the lateral and / or axial direction.
- control unit is designed to control the laser unit for generating the aperture diaphragm in such a way that light transmission through the aperture region of the lens is reduced to 20% or less.
- the aperture diaphragm has laser-induced changes in several planes which are spaced apart from one another in the axial direction.
- the control unit is designed in such a way that it can cause the laser unit to set the laser-induced lesions at different depths (along the visual axis of the eye).
- the aperture diaphragm can be constructed by a plurality of layers with changes, the layers, in particular if they each have a more or less regular distribution of the changes, being laterally offset from one another, for example by respective fractions of a periodicity of the lateral distribution of changes.
- An axial distribution of the changes, which is in the form of layers or the like, is not necessary, however, and the changes can also be arranged irregularly, for example randomly or at least quasi-randomly, in this regard too. In extreme cases, each individual change can be assigned its own level here.
- the individual laser-induced changes - at least insofar as they are arranged in one plane - do not necessarily have to be separable from one another, although a more or less continuous change in the form of areas which adjoin or merge into one another is also possible.
- the device has the laser unit for producing the aperture diaphragm in the intraocular lens implanted in the eye.
- the laser unit is not necessarily integrated with the control unit in a single device, so the control unit and laser unit can also be provided separately from one another in order to cooperate with one another only when the aperture diaphragm is actually being produced.
- the laser unit comprises a pulse laser unit with a pulse laser for delivering laser pulses, a focusing unit for focusing the laser pulses and a straightening unit for aligning the laser pulses, the pulse laser in particular for delivering laser pulses with a pulse duration in the range of 10,000 to 10 fs, preferably from 800 to 100 fs, particularly preferably from
- the laser pulses can be used to effect the desired change in the intraocular lens as a whole to produce the aperture.
- the control unit can also be configured to control the laser unit for generating the predetermined germ zone with laser pulses, the germ zone being formed by a permanent change in the material in the intraocular lens as a result of nonlinear absorption of a large number of laser pulses.
- the effect that leads to the material conversion can be brought about cumulatively, so that the desired local lack of transparency only occurs after a large number of laser pulses. Due to non-linear reactions, a small amount of heat remains in the irradiated focus volume with each applied laser pulse, which leads to a corresponding local temperature increase.
- this temperature increase does not have to have a permanent effect on the optical properties of the material.
- the temperature of the irradiated material will increase more or less if a second pulse and further pulses are applied at the same location or in the immediate vicinity of space and time.
- the spatial and temporal proximity of the second and subsequent laser pulses can now be designed in such a way that a temperature increase occurs locally, which results in a permanent change in the material.
- This change can be a carbonization or another chemical reaction that obscures or tints the irradiated Material and thus an absorption or a strong scattering of visible light.
- darkening zone coloring or carbonization zone can be understood as a synonym. If you place many of these darkening zones, each generated by a large number of laser pulses, next to each other, a surface is created that can be used as an aperture for visible light.
- the darkening zones can be generated in pulses by individual laser pulses. By placing several laser pulses close to each other, a continuous area of darkening can be created. The pulses can overlap in their focus volume or - in particular if the heat affected zone and thus the darkening extends beyond the focus volume - can be placed at greater intervals than the focus volume.
- the darkening zones can be placed side by side in one plane. However, several levels can also be generated if the desired attenuation of the incident, more visible light in one level is not sufficient and too much light transmits the darkening zones.
- the laser unit comprises a laser unit for a continuous laser beam with a laser source for generating a laser beam, a focusing unit for focusing the laser beam and a straightening unit for aligning the laser beam ,
- the laser source in particular for generating a laser beam with a power in the range from 0.1 mW to 100 W, preferably from 10 mW to 10 W, particularly preferably from 10 mW to 1 W, in a wavelength range from 400 to 1,400 nm, preferably from 600 to 1,200 nm, particularly preferably from 800 to 1,100 nm, very particularly preferably a power in a range from 10 mW to 500 mW at a wavelength in the range from 800 to 1,100 nm.
- the darkening zones introduced by the ultra-short laser pulses can be used as a germination zone for further darkening processes by laser energy supply.
- the necessary energy input essentially the input of Thermal energy
- the darkening effect occurs essentially with the speed of heat spreading.
- the trajectory to complete the aperture can, for example, describe a spiral, although other traces are also possible.
- the intraocular lens can itself be provided with a germination zone prior to implantation, for example doped with a small, strongly absorbing area (for example graphite).
- This area is advantageously small enough that it does not noticeably interfere with the visual process, since the intraocular lens is close to the main plane of the imaging system eye.
- This small area is preferably placed in such a way that after the implantation with the pupil in the normal position (i.e. not under mydriasis / dilation of the pupil) it lies behind the pupil and does not lie in the visual axis of the eye.
- the doped area can be used as a germination zone for further darkening processes by laser energy supply, so that the necessary energy input (essentially input of thermal energy) can take place by linear absorption at the darkening zones already present. There is no longer any need for nonlinear absorption.
- the laser exposure does not necessarily have to be pulsed anymore. Instead, continuous laser exposure can take place. The darkening effect occurs essentially with the speed of heat spreading.
- the computer program according to the invention can be provided, stored and / or distributed on a suitable storage medium, for example an optical storage medium or a non-volatile electronic storage medium. It can also be provided together with or as part of a hardware component.
- the computer program can also be provided in another way, for example via the Internet or via wired or wireless telecommunication means.
- FIG. 1 is a schematic representation for explaining the depth of field and the effect of an increased depth of field using a pinhole
- FIG. 3 shows a schematic illustration to explain a Te m pe ratu re i nt rag s in intraocular lens material
- Fig. 5 is a schematic representation to illustrate the process of creating an aperture in the implanted intraocular lens
- Fig. 6 are schematic representations for explaining processes in the creation of an aperture diaphragm according to the invention with previous marking.
- FIG. 1a and Fig. 1b An IOL 2, optimized in the eye 1 for the distance, bundles a parallel incident beam path from the distance 3 with a short depth of field 5a onto the retina of the eye 9.
- the light of an object up close 4 is imaged behind the retina 9 with a likewise short depth of field 5b due to the refractive power of the IOL 2 being too low.
- the depth-of-field area 7 for the imaging preferably increases to such an extent that both for close objects 4 and for the incident light 3 from a distance a sufficiently sharp image on the Retina 9 takes place.
- FIG. 2 shows schematic representations of an intraocular lens 2 with an aperture 6, FIG. 2a showing an example of an embodiment of a laser-generated aperture 6 within an IOL 2 in cross section and FIG. 2b an example of an embodiment of a laser-generated aperture 6 within an IOL 2 in plan view shows.
- Fig. 3 shows a schematic representation for explaining a temperature entry in intraocular lens material.
- a darkening zone 10 can be brought about in the material of the intraocular lens 2, as illustrated in FIG. 3a. If, in accordance with the illustration in FIG. 3b, a plurality of laser pulses 11 are placed close to one another, a continuous area of darkening can be produced. The focus volume of the pulses can overlap. If the heat affected zone generated by the laser pulse 11 and thus the obscuration 10 extends beyond the focus volume, the laser pulses 11 can be placed at greater intervals than the focus volume, as illustrated in FIG. 3c.
- FIG. 4 shows schematic representations for comparing a transmission with a single-layer arrangement of changes and a multi-layer arrangement of changes.
- a single layer arrangement of darkening zones (or general changes) 10 within the intraocular lens 2, as in this example, can result in incident light 12 being scattered or absorbed predominantly in all directions. Even if the changes 10 are arranged very densely, it can happen that a still considerable part of the incident light is scattered forward (13) and thus can reach the retina. In contrast, as illustrated in FIG. 4b, several layers of laterally densely packed changes 10 very largely reduce the probability that photons are scattered in the direction of the retina.
- the changes are to be arranged laterally as closely as possible. If the changes may not partially absorb the light, but only scatter it, it can still happen, even with a very dense lateral arrangement of the changes, that part of the incident light is scattered forward and thus reaches the retina (Fig. 4a). The scattered photons that reach the retina do not contribute to the formation of the image and are perceived as disturbing. Contrast vision in particular is negatively affected.
- FIG. 5 shows a schematic illustration to illustrate the process of creating an aperture in the implanted intraocular lens.
- FIG. 5a shows an (implanted) intraocular lens 2 with a germ zone 14. It is possible within the scope of the invention that this germ zone 14 is generated by one, a few or even many ultrashort laser pulses as a result of nonlinear absorption, the germ zone, for example, by Doping with graphite or the like is already provided in the intraocular lens before the implantation. These approaches can also be combined, it also being possible for the germ zone to be generated by laser action before the implantation. Following the situation shown in FIG. 5a, as indicated in FIG.
- FIG. 6 shows schematic representations to explain processes during the creation of an aperture diaphragm according to the invention with prior marking.
- one or more orientation points 22a, 22b can be lasered into the intraocular lens 2 with the aid of the laser beam 27, as shown in FIG. 6a.
- these can be two rings which indicate the rear (22a) and front position (22b) of the aperture opening.
- the lateral position of the markings is limited by the inner edge of the iris 24.
- Fig. 6b shows the same situation as in Fig. 6a from the operator's point of view (top view)
- FIG. 6c shows that when the pupil is wide (mydriasis), without the iris 24 shading the beam path of the laser 27, the complete aperture 6 can be lasered into the intraocular lens 2.
- FIG. 6d shows the same situation as in FIG. 6c from the operator's point of view (top view).
- the laser-generated aperture can be centered and oriented to the visual axis of the eye. For example, it is advantageous to position the center of the aperture in the middle between the pupil center and the so-called first Purkinje reflex. If the pupil has to be dilated with medication when using lasers (mydriasis), it is advantageous if a mark is first made on the surface of the cornea, for example by color, if the pupil is narrow.
- An advantageous positioning results from the centering and orientation on the iris 24 with a narrowed pupil (miosis).
- the eye is irritated by comparatively bright light.
- the eye adapts through a pupil constriction (miosis).
- one or more orientation points 22a, 22b can be lasered into the lens 2 by the laser 27, for example two rings, which indicate the rear and front positions of the aperture opening (FIGS. 6a, 6b).
- the positioning can be supported by conventional imaging, for example optical coherence tomography (OCT).
- the light stimulus is removed.
- the eye or both patient eyes are preferably left to maximum darkness.
- the eye will adapt the light situation again and dilate the pupil (mydriasis).
- the complete aperture 6 can now be lasered into the lens 2 without the iris 24 shading the beam path of the laser.
- the markings 22a, 22b previously set help center the aperture accordingly and orient it along the visual axis 23. If the natural mydriasis is not sufficient to completely move the iris 24 out of the beam path of the laser 27, the mydriasis can be expanded with medication. This procedure has the advantage that after the laser intervention, in bright daylight, the naturally closely adapted pupil matches the opening of the laser-generated aperture.
- the mask / aperture to be created in the IOL does not necessarily have to be a circular aperture. Rather, the shape of the aperture can be adapted to the visual defect to be corrected. For example, if there is an astigmatism as a visual defect, the aperture in the axis in which the astigmatism is present can be made smaller in its opening than in the axis in which there is no visual defect.
- individual components e.g. a processor, wholly or partly, taking over the functions of various elements mentioned in the claims.
- Processes or procedures such as controls, calculations, recordings or the like can be implemented as program means of a computer program and / or as special hardware components.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Prostheses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102018118714.9A DE102018118714A1 (de) | 2018-08-01 | 2018-08-01 | Vorrichtung und Verfahren zur Erzeugung einer Aperturblende in einer Intraokularlinse |
PCT/EP2019/070510 WO2020025616A1 (de) | 2018-08-01 | 2019-07-30 | Vorrichtung und verfahren zur erzeugung einer aperturblende in einer intraokularlinse |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3829502A1 true EP3829502A1 (de) | 2021-06-09 |
Family
ID=67539487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19749296.0A Pending EP3829502A1 (de) | 2018-08-01 | 2019-07-30 | Vorrichtung und verfahren zur erzeugung einer aperturblende in einer intraokularlinse |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210311324A1 (de) |
EP (1) | EP3829502A1 (de) |
CN (1) | CN112739296B (de) |
DE (1) | DE102018118714A1 (de) |
WO (1) | WO2020025616A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102021118003A1 (de) | 2021-07-13 | 2023-01-19 | Carl Zeiss Meditec Ag | Künstliche Augenlinse mit integrierter Bildprojektionsvorrichtung, elektronisches Informationssystem und Verfahren |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4955904A (en) | 1989-08-21 | 1990-09-11 | The Beth Israel Hospital Association | Masked intraocular lens and method for treating a patient with cataracts |
US5786883A (en) | 1991-11-12 | 1998-07-28 | Pilkington Barnes Hind, Inc. | Annular mask contact lenses |
US5980040A (en) | 1997-06-30 | 1999-11-09 | Wesley Jessen Corporation | Pinhole lens and contact lens |
WO2000052516A2 (en) | 1999-03-01 | 2000-09-08 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
ES2305109T3 (es) | 2000-09-26 | 2008-11-01 | Calhoun Vision Inc. | Ajuste de potencia de una lente ajustable. |
US10842675B2 (en) * | 2006-01-20 | 2020-11-24 | Lensar, Inc. | System and method for treating the structure of the human lens with a laser |
US9545338B2 (en) * | 2006-01-20 | 2017-01-17 | Lensar, Llc. | System and method for improving the accommodative amplitude and increasing the refractive power of the human lens with a laser |
US9889043B2 (en) * | 2006-01-20 | 2018-02-13 | Lensar, Inc. | System and apparatus for delivering a laser beam to the lens of an eye |
US20090137988A1 (en) * | 2007-11-02 | 2009-05-28 | Lensx Lasers, Inc | Methods And Apparatus For Improved Post-Operative Ocular Optical Performance |
WO2009070438A1 (en) | 2007-11-30 | 2009-06-04 | Bausch & Lomb Incorporated | Optical material and method for modifying the refractive index |
DE102008005053A1 (de) | 2008-01-18 | 2009-07-30 | Rowiak Gmbh | Laserkorrektur von Sehfehlern an der natürlichen Augenlinse |
ES2375442T3 (es) * | 2008-05-06 | 2012-02-29 | Novartis Ag | Lente intraocular no invasiva de potencia ajustable. |
US8292952B2 (en) * | 2009-03-04 | 2012-10-23 | Aaren Scientific Inc. | System for forming and modifying lenses and lenses formed thereby |
US9492272B2 (en) | 2009-08-13 | 2016-11-15 | Acufocus, Inc. | Masked intraocular implants and lenses |
US10085886B2 (en) * | 2010-01-08 | 2018-10-02 | Optimedica Corporation | Method and system for modifying eye tissue and intraocular lenses |
JP5722345B2 (ja) * | 2010-01-08 | 2015-05-20 | オプティメディカ・コーポレイション | 目組織および人工水晶体の変更システム |
EP2468226A1 (de) * | 2010-12-23 | 2012-06-27 | Rowiak GmbH | Steuerung für einen chirurgischen Laser |
WO2012135073A2 (en) * | 2011-03-25 | 2012-10-04 | Board Of Trustees Of Michigan State University | Adaptive laser system for ophthalmic use |
DE102011114251A1 (de) * | 2011-09-23 | 2013-03-28 | Vossamed Gmbh & Co. Kg | Optikanordnung und Verfahren zum Ermitteln der Ausrichtung einer künstlichen Linse |
US20130103012A1 (en) * | 2011-10-21 | 2013-04-25 | Robert Edward Grant | System and Method for Obviating Posterior Capsule Opacification |
US20130289543A1 (en) * | 2012-04-23 | 2013-10-31 | David Haydn Mordaunt | System and method for in situ creation of a small aperture intraocular lens |
US20150105760A1 (en) * | 2012-04-30 | 2015-04-16 | Lensgen, Inc. | Method and system for adjusting the refractive power of an implanted intraocular lens |
US9925621B2 (en) | 2012-11-14 | 2018-03-27 | Perfect Ip, Llp | Intraocular lens (IOL) fabrication system and method |
KR101444757B1 (ko) * | 2013-02-19 | 2014-09-30 | 주식회사 루트로닉 | 안과용 수술장치 |
EP3474910A1 (de) | 2016-06-23 | 2019-05-01 | Medicem Institute s.r.o. | Lichteinstellbares hydrogel und bioanaloge intraokularlinse |
-
2018
- 2018-08-01 DE DE102018118714.9A patent/DE102018118714A1/de active Pending
-
2019
- 2019-07-30 US US17/263,968 patent/US20210311324A1/en active Pending
- 2019-07-30 CN CN201980060470.8A patent/CN112739296B/zh active Active
- 2019-07-30 EP EP19749296.0A patent/EP3829502A1/de active Pending
- 2019-07-30 WO PCT/EP2019/070510 patent/WO2020025616A1/de unknown
Also Published As
Publication number | Publication date |
---|---|
DE102018118714A1 (de) | 2020-02-06 |
WO2020025616A1 (de) | 2020-02-06 |
CN112739296B (zh) | 2023-12-19 |
US20210311324A1 (en) | 2021-10-07 |
CN112739296A (zh) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60032746T2 (de) | Universell verwendbares implantat zur veränderung der hornhautkrümmung | |
EP1926454B1 (de) | Intraokularlinse | |
EP2907489A1 (de) | Vorrichtung für die vernetzung von okulärem gewebe mit elektromagnetischer strahlung | |
DE102008005053A1 (de) | Laserkorrektur von Sehfehlern an der natürlichen Augenlinse | |
WO2017194567A1 (de) | Augenchirurgisches verfahren | |
EP3200737B1 (de) | Planungsvorrichtung und verfahren zum erzeugen von steuerdaten für eine augenchirurgische behandlungsvorrichtung | |
EP2407132B1 (de) | Vorrichtung zum Präparieren eines Auges für das Einbringen von Photosensibilisator | |
DE102013218415A1 (de) | Augenchirurgisches Verfahren | |
DE102012018421A1 (de) | Augenchirurgische Refraktionskorrektur | |
WO2019170752A1 (de) | Shunt-implantat | |
DE102017207529A1 (de) | Nachbehandlung bei augenchirurgischer Refraktionskorrektur | |
WO2020025616A1 (de) | Vorrichtung und verfahren zur erzeugung einer aperturblende in einer intraokularlinse | |
WO2019086436A1 (de) | Vorrichtung zur erzeugung einer aperturblende im auge | |
EP3630473B1 (de) | Künstliche augenlinse mit darin ausgebildetem medikamentendepot und verfahren zum herstellen einer künstlichen augenlinse | |
DE102019134146B4 (de) | Verfahren zur Steuerung eines augenchirurgischen Lasers und Behandlungsvorrichtung | |
DE102021100509B4 (de) | Verfahren zur Steuerung eines augenchirurgischen Lasers, Computerprogrammprodukt sowie Behandlungsvorrichtung | |
EP4117579A1 (de) | Künstliche augenlinse | |
DE102021132290A1 (de) | Verfahren zum Steuern eines Lasers einer Laservorrichtung, Laservorrichtung, Computerprogramm sowie computerlesbares Medium | |
DE102022116734A1 (de) | Vorrichtungen und Verfahren zum Bereitstellen eines Volumenkörpers einer Kornea für eine Implantierung des Volumenkörpers in ein Auge eines Patienten | |
EP4117578A1 (de) | Künstliche augenlinse | |
DE202023107196U1 (de) | AddOn-PinHole Intraokulares Implantat zur Korrektur von Aberrationen höherer Ordnung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210301 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20231019 |